These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial. Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G; Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135 [TBL] [Abstract][Full Text] [Related]
3. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869 [TBL] [Abstract][Full Text] [Related]
4. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679 [TBL] [Abstract][Full Text] [Related]
5. Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction. Reindl M; Tiller C; Holzknecht M; Lechner I; Eisner D; Riepl L; Pamminger M; Henninger B; Mayr A; Schwaiger JP; Klug G; Bauer A; Metzler B; Reinstadler SJ Clin Res Cardiol; 2021 Jan; 110(1):61-71. PubMed ID: 32296969 [TBL] [Abstract][Full Text] [Related]
6. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A; JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801 [TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910 [TBL] [Abstract][Full Text] [Related]
9. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial. Achilli F; Malafronte C; Cesana F; Maggiolini S; Mauro C; De Ferrari GM; Lenatti L; Tespili M; Pasqualini P; Gentile F; Capogrossi MC; Maggioni A; Maseri A; Pontone G; Colombo GI; Pompilio G; Am Heart J; 2015 Oct; 170(4):652-658.e7. PubMed ID: 26386788 [TBL] [Abstract][Full Text] [Related]
10. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial. Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966 [TBL] [Abstract][Full Text] [Related]
11. [Predictive value of cardiac magnetic resonance imaging for adverse left ventricular remodeling after acute ST-segment elevation myocardial infarction]. Cui J; Liu W; Yan F; Zhao Y; Chen W; Luo C; Zhang X; Li T Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):553-562. PubMed ID: 38597447 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). Leone AM; Galiuto L; Garramone B; Rutella S; Giannico MB; Brugaletta S; Perfetti M; Liuzzo G; Porto I; Burzotta F; Niccoli G; Biasucci LM; Leone G; Rebuzzi AG; Crea F Am J Cardiol; 2007 Aug; 100(3):397-403. PubMed ID: 17659916 [TBL] [Abstract][Full Text] [Related]
13. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360 [TBL] [Abstract][Full Text] [Related]
14. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621 [TBL] [Abstract][Full Text] [Related]
15. Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment-Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis. Bulluck H; Carberry J; Carrick D; McEntegart M; Petrie MC; Eteiba H; Hood S; Watkins S; Lindsay M; Mahrous A; Ford I; Oldroyd KG; Berry C Circ Cardiovasc Imaging; 2020 Jul; 13(7):e009937. PubMed ID: 32689822 [TBL] [Abstract][Full Text] [Related]
16. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010 [TBL] [Abstract][Full Text] [Related]
17. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
19. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial. Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634 [TBL] [Abstract][Full Text] [Related]
20. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI). Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]